Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1982-04-21
1988-06-21
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
A61K 4900
Patent
active
047524715
ABSTRACT:
A method for detecting cancer comprises intradermally injecting into a patient a test preparation comprising a glycoprotein-polysaccharide-like antigenic substance admixed with the patient's blood serum. The patient's serum is also injected intradermally as a control and the physical dimensions of the erythemas of the injections measured and compared as an indication of the presence of cancer.
An initial antigenic substance is derived from cancerous tissues by disintegrating the tissue to enable the separation of the nuclei and cell membranes from the mitochondrial fraction of the cell. After lipids are removed from the mitochondrial fraction, it is hydrolyzed in hot alkali, dialyzed and then deproteinated. The cancer specificity of the antigenic substance is enhanced by gel filtration.
Prior to admixture with the antigenic substance, the blood serum is subjected to an adsorptive procedure to remove non-cancerous antibodies which might otherwise be reactive with the antigenic substance. A proteolytic enzyme (e.g. trypsin) is added to a portion of the blood serum to provide, in the preferred embodiment, additional cancer detection preparations.
REFERENCES:
British Medical Journal, Aug. 9, 1958, pp. 355-361.
LandOfFree
Cancer detection preparations and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer detection preparations and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer detection preparations and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-928901